Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Digestion. 2017;96(3):149-157. doi: 10.1159/000479625. Epub 2017 Aug 31.
Duodenal polyps and especially duodenal adenomas are a rare and mostly coincidental finding in patients undergoing upper gastrointestinal endoscopy. Due to their malignant potential, duodenal adenomas should be removed upon diagnosis. So far, the limited available data on the performance of endoscopic polypectomy show conflicting results with regard to adverse events and the adenoma recurrence rate.
After summarizing the currently available data, we retrospectively analyzed all patients undergoing endoscopic resection of nonampullary duodenal adenomas (NAD) at our institution between 2006 and 2016.
A total of 78 patients underwent endoscopic polypectomy for NAD adenoma. End-of-treatment success with complete resection requiring a mean of 1.2 interventions was achieved in 91% (n = 71). Procedural hemorrhage occurred in 12.8% (n = 10), whereas delayed bleeding was noted in 9% (n = 7). Duodenal perforation was registered and successfully treated in 2 cases (2.6%). No adenoma recurrence was noted following primary complete adenoma resection after a mean follow-up time of 33 months. Acute post-polypectomy bleeding was statistically significantly associated with large polyp size (p = 0.003) and lack of endoscopic prophylaxis (p = 0.0008). Delayed post-polypectomy bleeding showed a trend in the occurrence of large polyps (p = 0.064), and was statistically significantly associated with familial cancer syndrome (p = 0.019) and advanced histopathology (p = 0.013).
Our data suggest that endoscopic polypectomy of NAD is well feasible with high success rates. Procedural and delayed hemorrhage seems to be the primary issue rather than adenoma recurrence. We therefore advocate referral of patients with large NAD to experienced centers for endoscopic resection.
十二指肠息肉,尤其是十二指肠腺瘤,在上消化道内镜检查中是一种罕见的、多为偶然发现的疾病。由于其潜在的恶性程度,十二指肠腺瘤一经诊断应予以切除。目前,关于内镜下息肉切除术的有限数据显示,在不良事件和腺瘤复发率方面存在相互矛盾的结果。
在总结现有数据后,我们回顾性分析了 2006 年至 2016 年期间在我院接受内镜下非壶腹十二指肠腺瘤(NAD)切除术的所有患者。
共有 78 例患者因 NAD 腺瘤行内镜下息肉切除术。治疗结束时,91%(n=71)的患者完全切除成功,需要平均 1.2 次干预。12.8%(n=10)的患者发生治疗后出血,9%(n=7)的患者发生迟发性出血。2 例(2.6%)患者出现十二指肠穿孔,成功治疗。在平均 33 个月的随访后,原发性完全腺瘤切除后无腺瘤复发。急性内镜下息肉切除后出血与大息肉大小(p=0.003)和缺乏内镜预防(p=0.0008)显著相关。迟发性内镜下息肉切除后出血与大息肉的发生呈趋势相关(p=0.064),与家族性癌症综合征(p=0.019)和高级别组织病理学(p=0.013)显著相关。
我们的数据表明,NAD 的内镜下息肉切除术具有较高的成功率。手术和迟发性出血似乎是主要问题,而不是腺瘤复发。因此,我们主张将大 NAD 患者转介至有经验的中心进行内镜下切除。